ArticlePloS one2013

Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.

Eike Gallmeier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.